文献速递头颈技术与安全PETCT

11C-胆碱PET/CT用于甲状旁腺腺瘤的检测与定位

11C-Choline PET/CT for Detection and Localization of Parathyroid Adenomas.
PubMed 文献 · AJR Am J Roentgenol · 2017-11-15

该单机构回顾性研究评估了2005年1月至2016年2月间2933例前列腺癌男性的7088次11C-胆碱PET/CT扫描,识别出13例病理或实验室证实的甲状旁腺腺瘤,所有腺瘤均示踪剂摄取增高(SUVmax 5.6±3.0),作者结论认为在该患者人群中11C-胆碱PET/CT检测甲状旁腺腺瘤具有高特异性,并需前瞻性研究验证。

要点

  • 11C-胆碱PET/CT上甲状旁腺腺瘤均表现为示踪剂摄取增高,平均活性为血池的4.2倍、邻近甲状腺的2.1倍。
  • 13例腺瘤中仅1例为异位腺瘤,6例病理证实者均无包膜、血管或邻近组织侵犯等高危特征。
  • 3例PET/CT疑似甲状旁腺腺瘤者最终组织学诊断为甲状腺病变,且均无血钙或甲状旁腺激素异常。

核心结论

  • 在该患者人群中,11C-胆碱PET/CT检测甲状旁腺腺瘤具有高特异性。
  • 作者认为需前瞻性研究验证该结果并明确11C-胆碱PET/CT相对于其他检查方法的效用。

研究设计与样本

  • 单机构回顾性研究,评估2005年1月至2016年2月间2933例前列腺癌男性的7088次11C-胆碱PET/CT扫描。
  • 通过电子病历和相关影像回顾识别疑似甲状旁腺腺瘤患者,记录患者人口学、实验室结果和病灶特征。
  • 病理证实的甲状旁腺腺瘤以及影像或实验室检查符合诊断的病灶被视为阳性。

关键影像表现/征象

  • 13例男性(平均年龄72±7岁)经病理或实验室证实为甲状旁腺腺瘤,所有患者血清钙和甲状旁腺激素水平均异常升高。
  • 所有腺瘤在11C-胆碱PET/CT上均表现为示踪剂摄取增高,最大标准化摄取值(SUVmax)为5.6±3.0。
  • 腺瘤活性平均为血池的4.2倍、邻近甲状腺的2.1倍。
  • 发现1例异位甲状旁腺腺瘤。
  • 6例病理确诊者均未显示包膜、血管或邻近组织侵犯等高危特征。

诊断标准与关键数值

  • 甲状旁腺腺瘤阳性判定标准:病理证实,或影像/实验室检查符合诊断。
  • 所有腺瘤在11C-胆碱PET/CT上均示踪剂摄取增高,SUVmax为5.6±3.0。

临床应用与阅片要点

  • 在11C-胆碱PET/CT上,甲状旁腺腺瘤表现为局灶性示踪剂摄取增高,活性平均为血池的4.2倍、邻近甲状腺的2.1倍。
  • 需注意与甲状腺病变鉴别:3例PET/CT疑似甲状旁腺腺瘤者最终组织学诊断为甲状腺病变,但均无血钙或甲状旁腺激素异常。

局限性

  • 本研究为单机构回顾性研究。
  • 仅识别出13例甲状旁腺腺瘤患者。
  • 作者结论指出需前瞻性研究验证结果并明确11C-胆碱PET/CT相对于其他检查方法的效用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The purpose of this study is to determine the efficacy of 11C-choline PET/CT for the detection of parathyroid adenomas by retrospectively reviewing a large patient population.

MATERIALS AND METHODS: In this single-institution retrospective study, 7088 11C-choline PET/CT scans performed of 2933 men with prostate cancer from January 2005 through February 2016 were evaluated. Patients with suspected parathyroid adenomas were identified through a review of the electronic medical record and relevant imaging. Patient demographics, laboratory results, and lesion characteristics were noted. Pathologically proven parathyroid adenomas and lesions in patients with imaging or laboratory findings consistent with the diagnosis were considered positive.

RESULTS: Thirteen men (mean [± SD] age, 72 ± 7 years) with pathologically or laboratory-proven parathyroid adenomas were identified. All had abnormally elevated serum calcium and parathyroid hormone levels. All adenomas were tracer avid on 11C-choline PET/CT (maximum standardized uptake value, 5.6 ± 3.0), with activity averaging 4.2 times that of the blood pool and 2.1 times that of the adjacent thyroid. One case of an ectopic adenoma was identified. Of the six pathologically confirmed cases, none displayed high-grade features such as capsular, vascular, or adjacent tissue invasion. Three additional patients with possible parathyroid adenomas at 11C-choline PET/CT were ultimately found to have thyroid lesions on the basis of tissue diagnosis; however, none of these patients had abnormal calcium or parathyroid hormone levels.

CONCLUSION: In our patient population, 11C-choline PET/CT identified parathyroid adenomas with high specificity. Prospective investigation is warranted to validate this result and delineate the utility of 11C-choline PET/CT relative to other modalities.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Parvinian A, Martin-Macintosh EL, Goenka AH, et al. 11C-Choline PET/CT for Detection and Localization of Parathyroid Adenomas. AJR Am J Roentgenol. 2017. PMID: 29140118. doi:10.2214/AJR.17.18312

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。